Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurotech Solutions has developed the clinically validated MOXO Analytics Platform—a cloud-based digital tool used worldwide by clinicians to objectively assess attention profiles and support the diagnosis of ADHD. The platform provides measurable metrics on cognitive function using advanced analytics with unique distractor paradigms. It is ISO 13485 certified and supported by EU Horizon 2020 funding. The company’s solutions are widely adopted in clinical practice for both children and adults suspected of having attention disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurotech Solutions.